Daniel Long's most recent trade in Septerna Inc. was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Septerna Inc. | Daniel Long | SVP, Drug Discovery | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Aug 2025 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) |